Brazilian health regulator Anvisa has authorized resumption of a clinical trial of Johnson & Johnson's experimental COVID-19 vaccine, according to a statement from the government agency on Tuesday. The J&J vaccine is one of four being tested in Brazil, which has the world's third worst outbreak behind the United States and India, and the second-highest COVID-19 death toll. J&J's trial in Brazil had been suspended since Oct. 12, so a safety panel could evaluate an unexplained illness of a participant in its planned 60,000-person Phase III study.
Hence then, the article about brazil allows johnson johnson to resume trial of covid 19 vaccine was published today ( ) and is available onYahoo ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Brazil allows Johnson & Johnson to resume trial of COVID-19 vaccine )